News
Article
Brooke Hudspeth, PharmD, CDE, of the Kroger Co., discusses the newest therapies available for type 2 diabetes management.
Brooke Hudspeth, PharmD, CDE, of the Kroger Co., discusses the newest therapies available for type 2 diabetes management.
FDA Approves Dupilumab, Marking First Targeted Therapy in a Decade for Chronic Spontaneous Urticaria